|
|
|
Insider
Information: |
Boerner Christopher S. |
Relationship: |
Chief Executive Office... |
City: |
Bothell |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
173,563 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,709,682 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
173,563 |
|
|
Total
Value |
$20,709,682 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
-2.0
|
1.0
|
Percentage
Gain/Loss : |
-18.8%
|
17.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Seagen Inc |
SGEN |
Executive Vice Preside... |
2014-08-26 |
72,358 |
2011-08-19 |
0 |
Premium* |
|
Bristol-Myers Squibb Co |
BMY |
Chief Executive Office... |
2024-03-10 |
101,205 |
2019-02-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,215 |
41,325 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,643 |
42,818 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2021-03-10 |
4 |
D |
$60.93 |
$783,011 |
D/D |
(12,851) |
37,224 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2021-12-02 |
4 |
D |
$55.41 |
$74,804 |
D/D |
(1,350) |
38,512 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2021-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,638 |
39,862 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,399 |
49,270 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,715 |
81,649 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
13,417 |
94,282 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2022-03-10 |
4 |
D |
$68.42 |
$2,363,569 |
D/D |
(34,545) |
71,498 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2022-03-14 |
4 |
S |
$69.20 |
$2,043,526 |
D/D |
(29,532) |
41,966 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2022-12-02 |
4 |
D |
$81.13 |
$109,444 |
D/D |
(1,349) |
43,254 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2022-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,637 |
44,603 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,111 |
91,880 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2023-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
8,568 |
96,086 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
|
2023-03-10 |
4 |
D |
$65.71 |
$2,274,880 |
D/D |
(34,620) |
76,313 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2023-11-28 |
4 |
B |
$48.86 |
$150,049 |
D/D |
3,071 |
79,384 |
2.74 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2023-12-02 |
4 |
D |
$50.10 |
$67,635 |
D/D |
(1,350) |
80,672 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2023-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,638 |
82,022 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2023-12-05 |
4 |
B |
$49.78 |
$99,560 |
D/D |
2,000 |
82,672 |
2.74 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
54,638 |
129,769 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2024-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,698) |
115,180 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2024-03-10 |
4 |
D |
$53.79 |
$1,043,903 |
D/D |
(19,407) |
101,205 |
0 |
- |
|
47 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|